Baillie Gifford's position in Insulet is currently worth $578 Million. That's 0.48% of their equity portfolio (41st largest holding). The investor owns 3.20% of the outstanding Insulet stock. Baillie Gifford started to build up the position in Insulet in Q4 2023 and continued to invest until Q4 2024. Since then they sold 105 Thousand shares. The stake costed the investor $412 Million, netting the investor a gain of 40% so far.